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ABSTRACT
Objectives: People who are obese have higher
demands for medical care than those of the normal
weight people. However, in view of their shorter life
expectancy, it is unclear whether obese people have
higher lifetime medical expenditure. We examined the
association between body mass index, life expectancy
and lifetime medical expenditure.
Design: Prospective cohort study using individual data
from the Ohsaki Cohort Study.
Setting: Miyagi Prefecture, northeastern Japan.
Participants: The 41965 participants aged
40e79 years.
Primary and secondary outcome measures: The
life expectancy and lifetime medical expenditure aged
from 40 years.
Results: In spite of their shorter life expectancy, obese
participants might require higher medical expenditure
than normal weight participants. In men aged 40 years,
multiadjusted life expectancy for those who were
obese participants was 41.4 years (95% CI 38.28 to
44.70), which was 1.7 years non-signiﬁcantly shorter
than that for normal weight participants (p¼0.3184).
Multiadjusted lifetime medical expenditure for obese
participants was £112858.9 (94954.1e131840.9),
being 14.7% non-signiﬁcantly higher than that for
normal weight participants (p¼0.1141). In women
aged 40 years, multiadjusted life expectancy for those
who were obese participants was 49.2 years
(46.14e52.59), which was 3.1 years non-signiﬁcantly
shorter than for normal weight participants
(p¼0.0724), and multiadjusted lifetime medical
expenditure was £137765.9 (123672.9e152970.2),
being 21.6% signiﬁcantly higher (p¼0.0005).
Conclusions: According to the point estimate, lifetime
medical expenditure might appear to be higher for
obese participants, despite their short life expectancy.
With weight control, more people would enjoy their
longevity with lower demands for medical care.
INTRODUCTION
Obesity is closely associated with an increased
risk of cardiovascular disease, cancer, hyper-
tension, diabetes mellitus and other medical
problems. Previous studies have reported
that obese and overweight people have
higher needs and demands for medical care
than normal weight people.
1e5 However, it is
unclear whether obese people have higher
lifetime medical expenditure than those of
the normal weight people because the
former have a comparatively shorter life
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ARTICLE SUMMARY
Article focus
- Obese people have higher needs and demands
for medical care.
- Obesity is associated with an increased risk of
mortality.
- In view of the decreased life expectancy in obese
participants, it is unclear whether lifetime
medical expenditure increases or decreases as
a result.
Key messages
- In spite of their short life expectancy, obese
men and women had approximately 14.7% and
21.6% higher lifetime medical expenditure in
comparison with normal weight participants,
respectively.
- With better weight control, more people would
enjoy their longevity with lower needs and
demands for medical care.
Strengths and limitations of this study
- This is the ﬁrst study to have investigated the
association between body mass index, life
expectancy and lifetime medical expenditure
calculated from individual medical expenditure
and mortality data over a long period in a general
population.
- There was a limit to the accurate estimation of
life expectancy and lifetime medical expenditure
for obese participants because the Japanese
population has a low prevalence of body mass
index$30.0 kg/m
2.
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6e10 Additionally, underweight people have
a higher risk of mortality and thus also tend to have
higher medical expenditure per month or per person,
based on a 10-year follow-up.
14
Although four previous studies have examined the
association between obesity and lifetime medical
expenditure,
10e13 the results were inconsistent. One
study showed that obese people had lower lifetime
medical expenditure than those of the normal weight
people,
11 whereas the others indicated that obese people
had higher lifetime medical expenditure.
10 12 13 In
addition, two of the four studies estimated lifetime
medical expenditure from excess risk of cause-speciﬁc
mortality and mean medical expenditure for the index
disease.
10 11 Only the other two studies calculated life-
time medical expenditure on the basis of individual
medical expenditure and mortality.
12 13 However, one of
those studies followed up the participants for only
2 years
12 and the other calculated lifetime medical
expenditure for elderly participants aged 70 years or
over.
13 Therefore, the association between body mass
index (BMI) and lifetime medical expenditure remains
to be fully clariﬁed.
We therefore conducted a 13-year prospective obser-
vation of 41965 Japanese adults aged 40e79 years living
in the community, which accrued 392860 person-years.
We examined the association between BMI and lifetime
medical expenditure, based on individual medical
expenditure and life table analysis.
1 14e17 We collected
data for survival and all medical care utilisation and
costs, excluding home care services provided home
health aides, nursing home care and preventive health
services in participants of this cohort study.
MATERIALS AND METHODS
Study cohort
We used data from the Ohsaki National Health Insur-
ance (NHI) Cohort Study.
1 14 16e18 In brief, we sent
a self-administered questionnaire on various lifestyle
habits between October and December 1994 to all NHI
beneﬁciaries living in the catchment area of Ohsaki
Public Health Center, Miyagi Prefecture, northeastern
Japan. A survey was conducted of NHI beneﬁciaries aged
40e79 years. Among 54996 eligible individuals, 52029
(95%) responded.
We excluded 776 participants who had withdrawn
from the NHI before 1 January 1995, when we started
the prospective collection of NHI claim ﬁles. Thus,
51253 participants formed the study cohort. The study
protocol was approved by the Ethics Committee of
Tohoku University School of Medicine. The participants
who had returned the self-administered questionnaires
and had signed them were considered to have consented
to participate in this study.
For the current analysis, we also excluded participants
who did not provide information about body weight and
height (n¼3543), were at both extremes of the BMI
range: lower than the 0.05th percentile for BMI (below
14.41 for men; below 13.67 for women) or higher than
the 99.95th percentile for BMI (above 58.46 for men;
above 62.00 for women; n¼48), those who died within
the ﬁrst year (n¼454) or those who had a history of
cancer (n¼1533), myocardial infarction (n¼1233),
stroke (n¼831) or kidney disease (n¼1646). Thus,
a total of 41965 participants (20066 men and 21899
women) participated.
Body mass index
The self-administered questionnaire included questions
on weight and height, and BMI was calculated as weight
divided by the square of height (kilograms per square
metre). We divided the participants into groups according
to the following BMI categories: <18.5 (underweight),
18.5e24.9 (normal weight), 25.0e29.9 (overweight) and
$30.0 kg/m
2 (obesity). These BMI categories correspond
to the cut-off points proposed by the WHO: normal
BMI range (18.5e24.9 kg/m
2), grade 1 overweight
(25.0e29.9 kg/m
2), grade 2 overweight (30.0e39.9 kg/
m
2) and grade 3 overweight ($40.0 kg/m
2).
19
The validity of self-reported body weight and height
has been reported earlier.
1 Brieﬂy, the weight and height
of 14883 participants, who were a subsample of the
cohort, were measured during basic health examinations
provided by local governments in 1995. The Pearson
correlation coefﬁcient (r) and weighted k (k) between
the self-reported values and measured values were
r¼0.96 (p<0.01) for weight, r¼0.93 (p<0.01) for height
and r¼0.88 (p<0.01) and k¼0.72 for BMI categories.
Health insurance system in Japan
The details of the NHI system have been described
previously.
1 41 41 61 8Brieﬂy, everyone living in Japan is
required to enrol in one health insurance system. The
NHI covers 35% of the Japanese population for almost
all medical treatment, including diagnostic tests, medi-
cation, surgery, supplies and materials, physicians and
other personnel costs and most dental treatment. It also
covers home care services provided by physicians and
nurses but not those by other professionals such as home
health aides. The NHI covers inpatient care but not
nursing home care. Also, it does not cover preventive
health services such as mass screening and health
education. Payment to medical providers is made on
a fee-for-service basis, where the price of each service is
determined by a uniform national fee schedule.
If a participant withdrew from the NHI system because
of death, emigration or employment, the withdrawal
date and the reason for withdrawal were coded in the
NHI withdrawal history ﬁles. We recorded any mortality
or migration by reviewing the NHI withdrawal history
ﬁles and collected data on the death of participants by
reviewing the death certiﬁcates ﬁled at Ohsaki Public
Health Center. We then followed up the participants and
prospectively collected data on medical care utilisation
and its costs for all participants in the cohort from 1
January 1995 through 31 December 2007.
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We conducted the same analysis as the previous study
about the association between walking, life expectancy
and lifetime medical expenditure.
16 Brieﬂy, we divided
the age groups (3) from 40 years according to the
following categories: 40e44, 45e49, 50e54, 55e59,
60,64, 65e69, 70e74, 75e79, 80e84 and $85 years.
Based on person-years and the number of deaths from
1996 until 2007, the multiadjusted mortality rates for
each age category were estimated from a Poisson
regression model. The dependent variable was mortality,
and independent variables were age groups, categories
of BMI and the following covariates: smoking status
(current and past smoker or never smoker), alcohol
consumption (current drinker consuming 1e499 g/
week, current drinker consuming $450 g/week or never
and past drinker), sports and physical exercise ($3h /
week or <3 h/week), time spent walking ($1 h/week or
<1 h/week) and education (junior high school, high
school or college/university or higher). We did not
adjust for hypertension and diabetes mellitus in the
multivariate models because these variables are consid-
ered to occupy an intermediate position in the etiologic
pathway between BMI and mortality.
We separately calculated medical expenditure for
participants who survived through the index year and for
those who died because previous study showed that
medical expenditure increased before death.
20 The
multiadjusted medical expenditure per year was esti-
mated using a linear regression model adjusted for the
above covariates in survivors and decedents.
The estimates of multiadjusted mortality and medical
expenditure were used for estimating life expectancy
and lifetime medical expenditure from 40 years of age.
To estimate life expectancy and lifetime medical
expenditure, we constructed life tables per 100000
persons using Chiang’s analytical method on the basis of
the latest published complete life tables of Japan for the
year 2000.
21 22 Then, life expectancy (ex) and lifetime
medical expenditure (Mx) for each age groups (x) were
estimated using the numbers of survivors (lx), deaths
(dx), static population (Lx), multiadjusted medical
expenditure for survivors (ay) and multiadjusted medical
expenditure for the deceased (by) as follows:
+is sum ofy ¼ x
ex ¼
+Ly
lx
Mx ¼
+

Ly$ay þ dy$by

lx
The 95% CIs were estimated using a Monte Carlo
simulation based on a Poisson regression model and
linear regression model. We repeated 100000 times, and
all analysis were used the SAS V.9.1 statistical software
package (SAS Institute Inc., 2004). All p values <0.05
were accepted as statistically signiﬁcant.
We used a purchasing power parity rate of UK£
1.00¼ JPN\140.
16
RESULTS
After 13 years of follow-up, we observed 5159 deaths
(3356 men and 1803 women) among the 41965 partic-
ipants (20066 men and 21899 women).
The mean medical expenditure per year for survivors
in men was £2393 in underweight, £2055 in normal
weight, £2231 in overweight and £2334 in obesity,
respectively. In women, it was £2375 in underweight,
£1972 in normal weight, £2317 in overweight and £2733
in obesity, respectively. These differences of mean
medical expenditure per year for survivors are statisti-
cally signiﬁcant in men and women (ANOVA;
p<0.0001). Also, the mean medical expenditure in the
year of death for participants in men was £15445 in
underweight, £16973 in normal weight, £17811 in
overweight and £17878 in obesity, respectively. In
women, it was £12833 in underweight, £15584 in normal
weight, £17059 in overweight and £19635 in obesity,
respectively. These differences of mean medical expen-
diture in the year of death for participants are statisti-
cally signiﬁcant in only women (men, p¼0.2241; women,
p¼0.0059).
Baseline characteristics by BMI category
The baseline characteristics of the study participants
according to the BMI categories are shown for men and
women (table 1), among whom 3.3% and 3.9% were
underweight, 23.6% and 28.4% were overweight and
2.0% and 3.6% were obese, respectively.
Mean age in men decreased linearly with increasing
BMI category. In women, mean age was highest in the
underweight category. The proportions of men and
women who were current and past smokers decreased
with increasing BMI, and this tendency was especially
marked in men. The proportions of men who had never
and past drinker were highest in the underweight cate-
gory. The proportions of men who did $3 h sports and
physical exercise per week decreased with increasing
BMI. The proportions of men and women who walked
$1 h/day were the lowest in underweight men and
obese women. Educational background increased line-
arly in men and decreased linearly in women as the
BMI category increased. These characteristics showed
statistically signiﬁcant difference.
Mortality in terms of categories for BMI
Figure 1A for men and ﬁgure 1B for women show the
mortality (per 1000 person-years) in each of the age
groups according to the categories of BMI.
In underweight participants, there was a tendency that
the mortality was the highest in each age group.
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normal weight participants, especially women. Over-
weight men showed slightly lower mortality than normal
weight men. In obese participants, the mortality curve
was not described smoothly because of small number of
participants.
Table 2 shows the mortality ratio with 95% CIs
according to the categories of BMI. In underweight
participants, the multiadjusted mortality ratio was
signiﬁcantly higher than that in the normal weight
participants (men, 1.62, 95% CI 1.41 to 1.86, p<0.0001;
women, 1.46, 1.22 to 1.76, p<0.0001). In overweight
participants, the multiadjusted mortality ratio was
signiﬁcantly lower in men and non-signiﬁcantly lower in
women than that in normal weight participants (men,
0.91, 0.83 to 0.99, p¼0.0260; women, 0.98, 0.88 to 1.10,
p¼0.7841). In obese participants, the multiadjusted
mortality ratio was non-signiﬁcantly higher than that in
normal weight participants (men, 1.14, 0.88 to 1.49,
p¼0.3177; women, 1.23, 0.98 to 1.55, p¼0.0717).
Life expectancy and lifetime medical expenditure by BMI
category
Table 3 shows life expectancy and lifetime medical
expenditure with 95% CIs according to the BMI
categories.
By multiadjusted analysis, obese men and women had
approximately 1.7 and 3.1 years non-signiﬁcantly shorter
life expectancy from the age of 40 years in comparison
with men and women of normal weight, respectively
(men, p¼0.3184; women, p¼0.0724). Meanwhile, obese
men and women had approximately 14.7% non-signiﬁ-
cantly higher and 21.6% signiﬁcantly higher lifetime
medical expenditure in comparison with normal weight
participants, respectively (men, p¼0.1141; women,
p¼0.0005).
In men, multiadjusted life expectancy was greatest for
overweight, that is, 44.34 years (95% CI 43.11 to 45.54,
p¼0.0264), followed by normal weight (43.03 years,
42.22 to 43.73) and obesity (41.36 years, 38.28 to 44.70,
p¼0.3184) and was shortest for underweight
(37.40 years, 35.80 to 38.87, p<0.0001). The multi-
adjusted lifetime medical expenditure for overweight
was the highest, that is, £114766.9 (95% CI 107754.1 to
121966.6, p<0.0001), followed by obesity (£112858.9,
94954.1 to 131840.9, p¼0.1141) and normal weight
(£98355.0, 93615.3 to 103010.2) and was the lowest for
underweight (£93208.7, 81704.9 to 104706.4,
p¼0.3916).
In women, multiadjusted life expectancy was greatest
for overweight, that is, 52.56 years (50.67 to 54.46,
p¼0.7797), followed by normal weight (52.31 years,
Table 1 Baseline characteristics by BMI categories in 41965 participants
Men Women
BMI (kg/m
2)
p Value*
BMI (kg/m
2)
p Value <18.5 18.5e24.9 25.0e29.9 ‡30.0 <18.5 18.5e24.9 25.0e29.9 ‡30.0
No. of subjects 666 14278 4730 392 <0.0001 857 14031 6226 785 <0.0001
Mean age (years) 64.0 59.1 57.4 56.1 63.7 59.8 60.7 61.2
SD 10.4 10.5 10.2 10.2 10.9 10.1 9.1 9.5
Smoking status (%)
Current and
past smoker
87.3 82.5 76.6 74.8 <0.0001 18.6 11.2 10.1 10.6 <0.0001
Never smoker 12.7 17.5 23.4 25.2 81.4 88.8 90.0 89.4
Alcohol consumption (%)
Current drinker,
1e449 g/week
49.2 61.0 61.4 50.8 <0.0001 18.2 21.8 21.4 19.3 0.0574
Current drinker,
$450 g/week
9.6 11.7 12.6 15.0 0.6 0.8 0.5 0.9
Never and
past drinker
41.2 27.3 26.0 34.2 81.2 77.4 78.2 79.8
Sports and physical exercise (%)
$3 h/week 17.5 16.1 13.8 10.1 <0.0001 9.8 11.3 11.0 10.8 0.5993
<3 h/week 82.5 83.9 86.2 89.9 90.2 88.7 89.0 89.2
Time spent walking (%)
$1 h/day 41.7 51.4 45.8 42.7 <0.0001 37.9 45.1 41.0 35.6 <0.0001
<1 h/day 58.3 48.7 54.2 57.3 62.1 54.9 59.0 64.4
Education (%)
Junior high school 64.2 62.2 58.9 58.8 0.0013 58.3 54.2 62.7 71.3 <0.0001
High school 27.4 30.5 33.4 33.4 34.0 36.9 31.0 24.6
College/university
or higher
8.4 7.3 7.7 7.8 7.7 8.9 6.3 4.1
*p Values were calculated by c
2 test (categorical variables) or ANOVA (continuous variables).
BMI, body mass index.
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52.59, p¼0.0724) and was shortest for underweight
(46.98 years, 44.63 to 49.29, p<0.0001). The lifetime
medical expenditure for obesity was the highest
(£137765.9, 123672.9 to 152970.2, p¼0.0005), followed
by overweight (£129964.6, 121845.4 to 138577.2,
p<0.0001) and normal weight (£113282.9, 106668.0 to
120054.6) and was lowest for underweight (£109382.2,
97996.6 to 121008.6, p¼0.5174).
DISCUSSION
The present results indicate that (1) obese men and
women have 14.7% non-signiﬁcantly higher and 21.6%
signiﬁcantly higher multiadjusted lifetime medical
expenditure than those of the normal weight partici-
pants (men, p¼0.1141; women, p¼0.0005), even though
their life expectancy is non-signiﬁcantly shorter by 1.7
and 3.1 years than those of the normal weight partici-
pants, respectively (men, p¼0.3184; women, p¼0.0724);
(2) underweight men and women have 5.2% and 3.4%
non-signiﬁcantly lower lifetime medical expenditure
than those of the normal weight participants (men,
p¼0.5174; women, p¼0.3916) because men and women
live 5.6 and 5.3 years signiﬁcantly less than those of
the normal weight participants, respectively (men,
p<0.0001; women, p<0.0001).
Comparison with other studies
Obese participants had shorter life expectancy than
normal weight participants, as has been observed in
previous studies.
6e10 Overweight participants had longer
life expectancy than normal weight participants. Two of
the four previous studies have reported that overweight
participants had longer life expectancy than normal
weight participants.
79These results support our ﬁnding
of an association between being overweight and life
expectancy. Additionally, an association between BMI
and all-cause mortality in the Japanese population has
been reported by other data sets.
23e29 All seven previous
studies showed that among the BMI categories, the
lowest one had the highest mortality risk. These results
are consistent with the fact that underweight participants
have signiﬁcantly the shortest life expectancy, as was
observed in our study.
Thus, the association between BMI and life expectancy
showed same trend with the pooled analyses of the
association between BMI and all-cause mortality in Asia
and Japan.
30 31
Our present results support three of the four previous
studies of lifetime medical expenditure for obese
Table 2 Mortality ratio for BMI categories in 41965 participants
BMI (kg/m
2)
Univariate Multiadjusted*
Mortality ratio (95% CI) p Value Mortality ratio (95% CI) p Value
Men
<18.5 1.69 (1.47 to 1.93) <0.0001 1.62 (1.41 to 1.86) <0.0001
18.5e24.9 1.00 (Reference) 1.00 (Reference)
25.0e29.9 0.90 (0.82 to 0.98) 0.0163 0.91 (0.83 to 0.99) 0.0260
$30.0 1.13 (0.87 to 1.47) 0.3712 1.14 (0.88 to 1.49) 0.3177
Women
<18.5 1.50 (1.25 to 1.81) <0.0001 1.46 (1.22 to 1.76) <0.0001
18.5e24.9 1.00 (Reference) 1.00 (Reference)
25.0e29.9 1.00 (0.89 to 1.11) 0.9613 0.98 (0.88 to 1.10) 0.7841
$30.0 1.29 (1.03 to 1.62) 0.0273 1.23 (0.98 to 1.55) 0.0717
*Adjusted for age groups, smoking status, alcohol drinking, sports and physical exercise, time spent walking and education.
BMI, body mass index.
Figure 1 Multiadjusted mortality by BMI categories in each
age group in men (A) and women (B).
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10 12 13 In comparison to previous studies,
we calculated lifetime medical expenditure from indi-
vidual medical expenditure and survival data covering
longest follow-up period to date. Meanwhile, one study
has shown that obese participants have lower lifetime
medical expenditure than normal weight partici-
pants.
11 However, that study limited the participants to
non-smokers and calculated lifetime medical expendi-
ture from the mortality of a hypothetical cohort and
estimated medical expenditure from other cohort. In
the present study, overweight participants were found
to have higher lifetime medical expenditure than
normal weight participants, as had been reported
previously.
10 12 13 We consider that this was attributable
to the higher medical expenditure per month or per
person from the 10-year or 9-year follow-up than for
normal weight participants.
134On the other hand,
with regard to underweight participants, our present
ﬁndings were inconsistent with those of a previous
study that examined the association between being
underweight and lifetime medical expenditure.
13
However, that study calculated lifetime medical
expenditure for elderly participants aged over 70 years.
Elderly underweight participants have high mortality,
32
and medical expenditure increases in the 1 year prior
to death.
20 Thus, lifetime medical expenditure from
70 years for underweight participants becomes higher
than for participants of normal weight. Our study
results are thus inconsistent with those reported
previously.
We previously calculated life expectancy and lifetime
medical expenditure for smokers and non-smokers from
age 40 years by using the same data set as that for the
present study.
17 The results indicated that lifetime
medical expenditure was non-signiﬁcantly lower in
smokers than in non-smokers, reﬂecting the 3.5 years
shorter life expectancy of smokers. On the other hand,
the present study indicated that lifetime medical
expenditure was higher for obese participants in spite of
their shorter life expectancy. This difference would
result from the difference in which obesity and smoking
affect one’s health and longevity. Previous studies of
healthy and disability free life expectancy have agreed
that smoking shortens life expectancy without affecting
the years of life spent with ill-health or disability, while
obesity shortens life expectancy and extends the years of
life with ill-health or disability.
33 On the basis of these
differences, Reuser et al summarised the situation as
‘smoking kills and obesity disables’.
7 Extended years with
ill-health and/or disability must result in increased life-
time medical expenditure. All these ﬁndings suggest that
weight control would bring about longer life expectancy
and long-term enhancement of the quality of life and
a cost saving.
Strengths and limitations
A major strength of our present study is that it is the ﬁrst
in the world to have clariﬁed the association between
BMI and lifetime medical expenditure calculated from
individual medical expenditure and mortality data over
Table 3 Life expectancy and lifetime medical expenditure at age 40 years for BMI categories in 41965 participants
BMI (kg/m
2)
Univariate Multiadjusted*
Estimate 95% CI p Value Estimate 95% CI p Value
Men
Life expectancy at age 40 years (years)
<18.5 36.72 35.10 to 38.17 <0.0001 37.40 35.80 to 38.87 <0.0001
18.5e24.9 42.70 41.91 to 43.37 Reference 43.03 42.22 to 43.73 Reference
25.0e29.9 44.09 42.89 to 45.25 0.0157 44.34 43.11 to 45.54 0.0264
$30.0 41.23 38.16 to 44.54 0.3733 41.36 38.28 to 44.70 0.3184
Lifetime medical expenditure at age 40 years (£)
<18.5 94877.5 83411.4 to 106275.7 0.6846 93208.7 81704.9 to 104706.4 0.3916
18.5e24.9 97244.1 92662.5 to 101774.0 Reference 98355.0 93165.3 to 103010.2 Reference
25.0e29.9 114398.2 107490.1 to 121505.3 <0.0001 114766.9 107754.1 to 121966.6 <0.0001
$30.3 115362.6 97361.8 to 134555.0 0.0501 112858.9 94954.1 to 131840.9 0.01141
Women
Life expectancy at age 40 years (years)
<18.5 46.26 43.98 to 48.43 <0.0001 46.98 44.63 to 49.29 <0.0001
18.5e24.9 51.70 50.28 to 53.02 Reference 52.31 50.79 to 53.75 Reference
25.0e29.9 51.74 49.98 to 53.48 0.9582 52.56 50.67 to 54.46 0.7797
$30.0 48.13 45.23 to 51.22 0.0272 49.23 46.14 to 52.59 0.0724
Lifetime medical expenditure at age 40 years (£)
<18.5 108278.3 97142.8 to 119593.7 0.5816 109382.2 97996.6 to 121008.6 0.5174
18.5e24.9 111512.8 105303.4 to 117910.4 Reference 113282.9 106668.0 to 120054.6 Reference
25.0e29.9 127869.3 120236.3 to 135932.3 <0.0001 129964.6 121845.4 to 138577.2 <0.0001
$30.0 134887.1 121318.4 to 149383.6 0.0007 137765.9 123672.9 to 152970.2 0.0005
*Adjusted for age groups, smoking status, alcohol drinking, sports and physical exercise, time spent walking and education.
BMI, body mass index.
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40 years.
1 14 16e18 The NHI covers almost all medical care
utilisation.
1 4 14 16 18 Additionally, in order to reduce bias,
we adjusted confounders by including various covariates
in our Poisson regression model and linear regression
mode.
16 On the other hand, several limitations of our
study should also be considered. First, we used self-
reported BMI which in a source of error.
34 35 We consider
this error to be a non-differential misclassiﬁcation. This
misclassiﬁcation would lead to attenuation of the true
association towards the null. To address this problem, van
Dam et al
36 studied the association between BMI and
mortality using lower BMI cut-off points: 24.5 kg/m
2 to
reﬂect a measured BMI of 25.0 kg/m
2 and 29.0 kg/m
2 to
reﬂect a measured BMI of 30.0 kg/m
2. The association
showed similar with original cut-off points. Second, the
95% CI was wide, and there was a limit to the accurate
estimation of life expectancy and lifetime medical
expenditure for obese participants. Additionally, we did
not observe signiﬁcant association in obese participants
without lifetime medical expenditure in women.
However, our results are consistent with those of the
previous studies.
6e81 01 21 3In Japan, prevalence of obesity
is only 3%.
37 Thus, the reason for non-signiﬁcant associ-
ation might be b error because of the lack of statistical
power due to small number of obese participants.
Conclusions and policy implication
In summary, even though we observed non-signiﬁcant
association between obesity, life expectancy and lifetime
medical expenditure without lifetime medical expendi-
ture in women, lifetime medical expenditure might
appear to be higher for obese participants, despite their
short life expectancy. With better weight control, more
people would enjoy their longevity with lower needs and
demands for medical care.
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